ArticleInternational journal of general medicine2021

CSMD1 Mutation Related to Immunity Can Be Used as a Marker to Evaluate the Clinical Therapeutic Effect and Prognosis of Patients with Esophageal Cancer.

Xin Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.